{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:21:10Z","timestamp":1764030070584,"version":"3.45.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.breast.2025.104596","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T13:37:34Z","timestamp":1760535454000},"page":"104596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Denosumab versus zoledronic acid: analgesic and survival impact of an extended treatment regimen beyond 2 years in breast cancer"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1689-0370","authenticated-orcid":false,"given":"Ernesto","family":"Zecca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Zambelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Tin\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Bracchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalba","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Pigni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Lo Dico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ricchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4637-9821","authenticated-orcid":false,"given":"Giacomo","family":"Massa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Caraceni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.breast.2025.104596_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.breast.2025.104596_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.canlet.2008.05.044","article-title":"Osteotropic cancers: from primary tumor to bone","volume":"273","author":"Buijs","year":"2009","journal-title":"Cancer Lett"},{"issue":"8 Suppl","key":"10.1016\/j.breast.2025.104596_bib3","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.breast.2025.104596_bib4","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.3390\/cancers14235727","article-title":"Bone metastasis of breast cancer: molecular mechanisms and therapeutic strategies","volume":"14","author":"Pang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.breast.2025.104596_bib5","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/bonekey.2015.58","article-title":"Acidic microenvironment and bone pain in cancer-colonized bone","volume":"4","author":"Yoneda","year":"2015","journal-title":"BoneKEy Rep"},{"key":"10.1016\/j.breast.2025.104596_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1239599","article-title":"Ion channels in cancer-induced bone pain: from molecular mechanisms to clinical applications","volume":"16","author":"Lu","year":"2023","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"10.1016\/j.breast.2025.104596_bib7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00109-024-02464-2","article-title":"Molecular targets in bone cancer pain: a systematic review of inflammatory cytokines","volume":"102","author":"Ruivo","year":"2024","journal-title":"J Mol Med (Berl)"},{"issue":"6","key":"10.1016\/j.breast.2025.104596_bib8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jpain.2010.12.016","article-title":"Breast cancer-induced bone remodeling, skeletal pain, and sprouting of sensory nerve fibers","volume":"12","author":"Bloom","year":"2011","journal-title":"J Pain"},{"issue":"1","key":"10.1016\/j.breast.2025.104596_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00000542-200501000-00022","article-title":"Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain","volume":"102","author":"Donovan-Rodriguez","year":"2005","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.breast.2025.104596_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00774-014-0574-x","article-title":"Inhibitory effect of bisphosphonate on osteoclast function contributes to improved skeletal pain in ovariectomized mice","volume":"33","author":"Abe","year":"2015","journal-title":"J Bone Miner Metabol"},{"issue":"1","key":"10.1016\/j.breast.2025.104596_bib11","article-title":"Does zoledronic acid provide a good clinical outcome in patients with chronic back pain associated with vertebral osteoporosis?","volume":"15","author":"M","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.breast.2025.104596_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0269216316639793","article-title":"Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: a systematic review within the European association for palliative care guidelines project","volume":"31","author":"Porta-Sales","year":"2017","journal-title":"Palliat Med"},{"issue":"35","key":"10.1016\/j.breast.2025.104596_bib13","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1200\/JCO.2017.75.4614","article-title":"Role of bone-modifying agents in metastatic breast cancer: an American society of clinical Oncology-Cancer care Ontario focused guideline update","volume":"35","author":"Van Poznak","year":"2017","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.breast.2025.104596_bib14","doi-asserted-by":"crossref","first-page":"iii124","DOI":"10.1093\/annonc\/mdu103","article-title":"Bone health in cancer patients: ESMO clinical practice guidelines","volume":"25","author":"Coleman","year":"2014","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.breast.2025.104596_bib15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1200\/JOP.2017.027672","article-title":"Role of bone-modifying agents inMetastatic breast cancer: an American society of clinical Oncology-Cancer Care Ontario Focused Guideline update Summary","volume":"13","author":"Van Poznak","year":"2017","journal-title":"J Oncol Pract"},{"issue":"10","key":"10.1016\/j.breast.2025.104596_bib16","article-title":"Bisphosphonates and other bone agents for breast cancer","volume":"10","author":"O'Carrigan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.breast.2025.104596_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.breast.2012.04.008","article-title":"Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasis","volume":"21","author":"Ding","year":"2012","journal-title":"Breast"},{"issue":"10","key":"10.1016\/j.breast.2025.104596_bib18","first-page":"3859","article-title":"Optimizing antiresorptive treatment in patients with bone metastases: time to initiation, switching strategies, and treatment duration","volume":"27","author":"Mjelstad","year":"2019","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.breast.2025.104596_bib19","first-page":"925","article-title":"Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review","volume":"29","author":"Ng","year":"2021","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.breast.2025.104596_bib20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"35","key":"10.1016\/j.breast.2025.104596_bib21","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.breast.2025.104596_bib22","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/cncr.27789","article-title":"Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid","volume":"119","author":"Cleeland","year":"2013","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.breast.2025.104596_bib23","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.breast.2025.104596_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","article-title":"Using the common terminology criteria for adverse events (CTCAE - Version 5.0) to evaluate the severity of adverse events of anticancer therapies","volume":"112","author":"Freites-Martinez","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.breast.2025.104596_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104565","article-title":"Denosumab versus zoledronic acid in metastatic breast cancer: a retrospective observational analysis of 24-dose regimens on analgesia and skeletal-related event prevention","volume":"83","author":"Massa","year":"2025","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.breast.2025.104596_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/03007995.2018.1545636","article-title":"Effectiveness of denosumab on back pain-related disability and quality-of-life in patients with vertebral fragility fractures","volume":"35","author":"Moretti","year":"2019","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.breast.2025.104596_bib27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jos.2016.11.017","article-title":"Denosumab and alendronate treatment in patients with back pain due to fresh osteoporotic vertebral fractures","volume":"22","author":"Tetsunaga","year":"2017","journal-title":"J Orthop Sci"},{"issue":"8","key":"10.1016\/j.breast.2025.104596_bib28","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.breast.2025.104596_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00774-023-01408-z","article-title":"Differences between zoledronic acid and denosumab for breast cancer treatment","volume":"41","author":"Ishikawa","year":"2023","journal-title":"J Bone Miner Metabol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625006137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625006137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:16:48Z","timestamp":1764029808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977625006137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"alternative-id":["S0960977625006137"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104596","relation":{},"ISSN":["0960-9776"],"issn-type":[{"type":"print","value":"0960-9776"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Denosumab versus zoledronic acid: analgesic and survival impact of an extended treatment regimen beyond 2 years in breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104596"}}